Who should avoid IGF-1 LR3 Certain individuals should not use IGF-1 LR3 under any circumstances: Absolute Contraindications : Active cancer or history of hormone-sensitive tumors Severe diabetes or uncontrolled blood sugar Pregnancy or nursing mothers History of organ enlargement Active blood clotting disorders Relative Contraindications (may require specialty medical clearance): History of diabetes Cardiovascular conditions Autoimmune disorders Kidney or liver dysfunction History of growth disorders Before starting IGF-1 LR3, comprehensive health screening is essential
Although MOTS-C has gained attention in wellness and longevity spaces, it is not FDA-approved for improving metabolism, enhancing exercise performance, boosting energy, supporting weight management, or treating any medical condition
Understand the difference between medical spa and day spa services, including injectables, lasers, supervision, safety, and treatment planning
The moderate Sermorelin peptide side effects may not be enough to deter many people from taking the medication
Used together at the same time, the GH pulse they produce is significantly larger than either achieves alone
Proper storage and handling practices help preserve product integrity, stability, and overall quality
